Intranasal gemcitabine eradicates osteosarcoma lung metastases

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1331, 2002-01, pp. : 12-12

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Histone Deacetylase Inhibitor, MS-275 (Entinostat), Downregulates c-FLIP, Sensitizes Osteosarcoma Cells to FasL, and Induces the Regression of Osteosarcoma Lung Metastases

By  

Current Cancer Drug Targets, Vol. 13, Iss. 4, 2013-05 ,pp. : 411-422

Bentham Science Publishers

Access to resources Recommend Favorite

Erlotinib/gemcitabine: Lung and skin disorders: case report

By  

Reactions Weekly, Vol. 1, Iss. 1170, 2007-01 ,pp. : 16-17

Adis International

Access to resources Recommend Favorite

Docetaxel/gemcitabine: Lung disorders: 2 case reports

By  

Reactions Weekly, Vol. 1, Iss. 1157, 2007-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

Gemcitabine: Lung injury: 15 case reports

By  

Reactions Weekly, Vol. 1, Iss. 1419, 2012-01 ,pp. : 24-24

Adis International

Access to resources Recommend Favorite

Gemcitabine in non-small cell lung cancer

By Cappuzzo Federico   Crinò Lucio  

Expert Opinion on Pharmacotherapy, Vol. 3, Iss. 6, 2002-06 ,pp. : 745-753

Informa Healthcare

Access to resources Recommend Favorite